Precigen (PGEN) Operating Income (2016 - 2025)
Precigen (PGEN) has disclosed Operating Income for 14 consecutive years, with -$34.5 million as the latest value for Q3 2025.
- On a quarterly basis, Operating Income fell 62.17% to -$34.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$117.4 million, a 16.61% increase, with the full-year FY2024 number at -$135.0 million, down 35.36% from a year prior.
- Operating Income was -$34.5 million for Q3 2025 at Precigen, down from -$31.8 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of -$7.6 million in Q3 2022 to a low of -$60.8 million in Q2 2024.
- A 5-year average of -$26.2 million and a median of -$23.5 million in 2023 define the central range for Operating Income.
- Peak YoY movement for Operating Income: skyrocketed 64.64% in 2022, then tumbled 188.07% in 2024.
- Precigen's Operating Income stood at -$33.1 million in 2021, then surged by 34.18% to -$21.8 million in 2022, then plummeted by 57.01% to -$34.2 million in 2023, then rose by 16.68% to -$28.5 million in 2024, then decreased by 20.92% to -$34.5 million in 2025.
- Per Business Quant, the three most recent readings for PGEN's Operating Income are -$34.5 million (Q3 2025), -$31.8 million (Q2 2025), and -$22.6 million (Q1 2025).